208 related articles for article (PubMed ID: 23264618)
21. Disulfide scrambling in superoxide dismutase 1 reduces its cytotoxic effect in cultured cells and promotes protein aggregation.
Leinartaitė L; Johansson AS
PLoS One; 2013; 8(10):e78060. PubMed ID: 24143259
[TBL] [Abstract][Full Text] [Related]
22. Screening of Drugs Inhibiting In vitro Oligomerization of Cu/Zn-Superoxide Dismutase with a Mutation Causing Amyotrophic Lateral Sclerosis.
Anzai I; Toichi K; Tokuda E; Mukaiyama A; Akiyama S; Furukawa Y
Front Mol Biosci; 2016; 3():40. PubMed ID: 27556028
[TBL] [Abstract][Full Text] [Related]
23. Monomerized Cu, Zn-superoxide dismutase induces oxidative stress through aberrant Cu binding.
Kishigami H; Nagano S; Bush AI; Sakoda S
Free Radic Biol Med; 2010 Apr; 48(7):945-52. PubMed ID: 20079423
[TBL] [Abstract][Full Text] [Related]
24. Metal deficiency increases aberrant hydrophobicity of mutant superoxide dismutases that cause amyotrophic lateral sclerosis.
Tiwari A; Liba A; Sohn SH; Seetharaman SV; Bilsel O; Matthews CR; Hart PJ; Valentine JS; Hayward LJ
J Biol Chem; 2009 Oct; 284(40):27746-58. PubMed ID: 19651777
[TBL] [Abstract][Full Text] [Related]
25. An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis.
Ray SS; Nowak RJ; Strokovich K; Brown RH; Walz T; Lansbury PT
Biochemistry; 2004 May; 43(17):4899-905. PubMed ID: 15109247
[TBL] [Abstract][Full Text] [Related]
26. Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction.
Tiwari A; Hayward LJ
J Biol Chem; 2003 Feb; 278(8):5984-92. PubMed ID: 12458194
[TBL] [Abstract][Full Text] [Related]
27. Disulfide-reduced ALS variants of Cu, Zn superoxide dismutase exhibit increased populations of unfolded species.
Kayatekin C; Zitzewitz JA; Matthews CR
J Mol Biol; 2010 Apr; 398(2):320-31. PubMed ID: 20184893
[TBL] [Abstract][Full Text] [Related]
28. Fully metallated S134N Cu,Zn-superoxide dismutase displays abnormal mobility and intermolecular contacts in solution.
Banci L; Bertini I; D'Amelio N; Gaggelli E; Libralesso E; Matecko I; Turano P; Valentine JS
J Biol Chem; 2005 Oct; 280(43):35815-21. PubMed ID: 16105836
[TBL] [Abstract][Full Text] [Related]
29. Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS.
Karch CM; Prudencio M; Winkler DD; Hart PJ; Borchelt DR
Proc Natl Acad Sci U S A; 2009 May; 106(19):7774-9. PubMed ID: 19416874
[TBL] [Abstract][Full Text] [Related]
30. Dynamical roles of metal ions and the disulfide bond in Cu, Zn superoxide dismutase folding and aggregation.
Ding F; Dokholyan NV
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19696-701. PubMed ID: 19052230
[TBL] [Abstract][Full Text] [Related]
31. Structural analysis of the overoxidized Cu/Zn-superoxide dismutase in ROS-induced ALS filament formation.
Baek Y; Woo TG; Ahn J; Lee D; Kwon Y; Park BJ; Ha NC
Commun Biol; 2022 Oct; 5(1):1085. PubMed ID: 36224351
[TBL] [Abstract][Full Text] [Related]
32. Redox properties of the disulfide bond of human Cu,Zn superoxide dismutase and the effects of human glutaredoxin 1.
Bouldin SD; Darch MA; Hart PJ; Outten CE
Biochem J; 2012 Aug; 446(1):59-67. PubMed ID: 22651090
[TBL] [Abstract][Full Text] [Related]
33. Mapping superoxide dismutase 1 domains of non-native interaction: roles of intra- and intermolecular disulfide bonding in aggregation.
Wang J; Xu G; Borchelt DR
J Neurochem; 2006 Mar; 96(5):1277-88. PubMed ID: 16441516
[TBL] [Abstract][Full Text] [Related]
34. Modeling of mutant superoxide dismutase 1 octamers with cross-linked disulfide bonds.
Zhang A; Teigen K; Kouznetsova VL; Tsigelny IF
J Mol Model; 2022 Mar; 28(4):89. PubMed ID: 35279789
[TBL] [Abstract][Full Text] [Related]
35. Human SOD1 before harboring the catalytic metal: solution structure of copper-depleted, disulfide-reduced form.
Banci L; Bertini I; Cantini F; D'Amelio N; Gaggelli E
J Biol Chem; 2006 Jan; 281(4):2333-7. PubMed ID: 16291742
[TBL] [Abstract][Full Text] [Related]
36. Different regulation of wild-type and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria.
Kawamata H; Manfredi G
Hum Mol Genet; 2008 Nov; 17(21):3303-17. PubMed ID: 18703498
[TBL] [Abstract][Full Text] [Related]
37. A copper chaperone-mimetic polytherapy for SOD1-associated amyotrophic lateral sclerosis.
McAlary L; Shephard VK; Wright GSA; Yerbury JJ
J Biol Chem; 2022 Mar; 298(3):101612. PubMed ID: 35065969
[TBL] [Abstract][Full Text] [Related]
38. Oxidative modification to cysteine sulfonic acid of Cys111 in human copper-zinc superoxide dismutase.
Fujiwara N; Nakano M; Kato S; Yoshihara D; Ookawara T; Eguchi H; Taniguchi N; Suzuki K
J Biol Chem; 2007 Dec; 282(49):35933-44. PubMed ID: 17913710
[TBL] [Abstract][Full Text] [Related]
39. Redox environment is an intracellular factor to operate distinct pathways for aggregation of Cu,Zn-superoxide dismutase in amyotrophic lateral sclerosis.
Furukawa Y
Front Cell Neurosci; 2013; 7():240. PubMed ID: 24348334
[TBL] [Abstract][Full Text] [Related]
40. Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis.
Rakhit R; Chakrabartty A
Biochim Biophys Acta; 2006; 1762(11-12):1025-37. PubMed ID: 16814528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
